Summary: The RAS Initiative was launched in 2013 to address unmet clinical needs of patients with KRAS-driven cancers. The Initiative is based at Frederick National Laboratory for Cancer Research in Frederick, MD, and involves multiple collaborations with the RAS research community in academia and industry with the shared goal of developing RAS therapies.

中文翻译：

---

RAS 40 周年：RAS 计划的更新

摘要：RAS 计划于 2013 年启动，旨在解决 KRAS 驱动的癌症患者未得到满足的临床需求。该计划以马里兰州弗雷德里克的弗雷德里克国家癌症研究实验室为基础，涉及与学术界和工业界 RAS 研究界的多项合作，共同目标是开发 RAS 疗法。